We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Novel Chemical Entities in Psychedelics: Risks and Rewards for Investors

Join us for an exclusive panel discussion focused on research and development relating to novel chemical entities in the psychedelics industry and some of the viable business models that are emerging in this field.

Delivered by five experienced PhD scientists, this panel will provide insight into valuable areas of ongoing research, perspectives on the future of the psychedelic drug development landscape, pitfalls to avoid, and how ethical considerations play into long term profits for companies.

During this panel we will cover:

  • Psychedelics research and development
  • The future of this rapidly developing industry
  • How investors can understand where the risks and rewards lie in the psychedelics space